Clinical trial · Interventional
Advanced Gastrointestinal Endoscopic Imaging
NCT01034670CI-TRIAL-00078295terminatedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Change in personnel and cessation of funding
Summary
Brief summary (as posted)
To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric (Stomach) Cancer | Childhood Gastric Carcinoma | ALIAS | 0.90 |
| Gastrointestinal Diseases | — | UNRESOLVED | — |
| Gastrointestinal Stromal Tumor (GIST) | Gastrointestinal Stromal Tumor | CURATED_BROADER | 0.80 |
Interventions
Interventions (6)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CellVizio | Device | — | UNRESOLVED |
| Dual axis endoscopic microscope | Device | — | UNRESOLVED |
| fluorescein | Drug | — | UNRESOLVED |
| fluorescent Peptide | Drug | — | UNRESOLVED |
| indocyanine green | Drug | — | UNRESOLVED |
| wide field fluorescence system | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- endoscopy arm
- description
- imaging performed in conjunction with the regularly scheduled endoscopy during which the newer imaging techniques will be used to detect premalignant conditions. includes wide field fluorescence, microscopy, Raman spectroscopy and/or ultrasound.
- interventionNames
- Device: Dual axis endoscopic microscope
- Device: wide field fluorescence system
- Device: CellVizio
- Drug: fluorescent Peptide
- Drug: fluorescein
- Drug: indocyanine green
Primary outcomes (1)
- measure
- Number of Participants With Successful Imaging of the Mucosa
- timeFrame
- 5 years
- description
- Detection of mucosa abnormailities as a first step in the goal of detection of neoplasia
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria:patients be at least 18 years of age, Either genders All ethnic backgrounds will be considered. Patients who are scheduled for endoscopy by one of the investigators will be asked if they are interested in participating in the study. The study will be open to all patients undergoing endoscopy that do not have exclusion criteria. We will ask all patients if they are participating in any other studies. If they are participating in any other study then we will ask them for more information to determine whether there could be any harm from participating in both studies and if there is then they will not be enrolled. Exclusion Criteria:Patients with unstable vital signs will not be included.
References
Publications (0)
Data not yet available
No reference posted for this study.